rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Evaxion A/S - American Depositary Share

EVAX · Nasdaq

Health CareBiotechnologyNot moving yet

EVAX stood above a rising 150-day average in 13 of the last 52 weekly readings, and has been out of that trend for the last 39 weeks. It is 19.1% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 39
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
19 (+3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 13 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders19+3 on the quarter
New · exited4 · 1
Reported value$4.9M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Merck & Co., Inc.unchanged · filed 7 Aug 20261,214,126$3.8M00.0%
Ikarian Capital, LLCunchanged · filed 14 Aug 202674,698$232K00.0%
Rathbones Group PLCunchanged · filed 23 Jul 202645,723$142K00.0%
CITADEL ADVISORS LLCadded · filed 14 Aug 202636,584$113K+18,811+105.8%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 202633,800$105K-5,425−13.8%
Annis Gardner Whiting Capital Advisors, LLCunchanged · filed 10 Aug 202630,000$93K00.0%
J. Safra Sarasin Holding AGnew · filed 31 Jul 202622,896$71K+22,896
RHUMBLINE ADVISERSadded · filed 12 Aug 202621,849$68K+190+0.9%
JANE STREET GROUP, LLCnew · filed 14 Aug 202620,581$64K+20,581
BOOTHBAY FUND MANAGEMENT, LLCunchanged · filed 14 Aug 202618,426$57K00.0%
31 Dec 2023 – 30 Jun 2026
21018Dec 23Sep 24Mar 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

Nobody on record has traded it.

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 31 Dec 2025495%

Analyst forecasts

No analyst forecasts yet.